Gullik Håkan Wickholm
Director/Miembro de la Junta en Beactica Therapeutics AB .
Cargos activos de Gullik Håkan Wickholm
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Director/Miembro de la Junta | 01/01/2018 | - |
| GHW Consulting AB | Director/Miembro de la Junta | - | - |
Historial de carrera de Gullik Håkan Wickholm
Antiguos cargos conocidos de Gullik Håkan Wickholm.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AstraZeneca AS | Corporate Officer/Principal | - | - |
| GENOVIS AB | Director/Miembro de la Junta | 01/01/2019 | - |
| LYTIX BIOPHARMA | Director Ejecutivo | 01/01/2014 | 07/09/2017 |
| Corporate Officer/Principal | 07/09/2017 | - |
Formación de Gullik Håkan Wickholm.
| University of Uppsala | Undergraduate Degree |
Estadísticas
Internacional
| Suecia | 5 |
| Noruega | 3 |
Operativa
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GENOVIS AB | Health Technology |
| LYTIX BIOPHARMA | Health Technology |
| Empresas privadas | 3 |
|---|---|
| AstraZeneca AS | |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
| GHW Consulting AB |
